Literature DB >> 31170095

Status of hypertension in Europe.

Hannes Reuter1,2,3, Jens Jordan1,4,5.   

Abstract

PURPOSE OF REVIEW: Arterial hypertension is the leading preventable cause of cardiovascular disease worldwide. Effective European programs aiming to improve awareness, treatment, and control of hypertension are lacking. RECENT
FINDINGS: Europe is heading the statistics for hypertension prevalence and cardiovascular disease. On the one hand this predominance reflects the increasing life expectancy in European population, whereas on the other hand, it can be attributed to the sedentary lifestyle and the nutritional habits of wealthy societies. Despite its economic power, Europe also ranges among the regions with the lowest rates of hypertension awareness and control worldwide.
SUMMARY: The present study discusses the influence of medical inertia, insufficient patient education, contradictory recommendations from the European and independent national societies, the need for hypertension programs, as well as differences in health policies in Europe as potential factors that may contribute to this discrepancy.

Entities:  

Year:  2019        PMID: 31170095     DOI: 10.1097/HCO.0000000000000642

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  1 in total

1.  Polypharmacy in the Management of Arterial Hypertension-Friend or Foe?

Authors:  Camelia Cristina Diaconu; Matei-Alexandru Cozma; Elena-Codruța Dobrică; Gina Gheorghe; Alexandra Jichitu; Vlad Alexandru Ionescu; Alina Crenguța Nicolae; Cristina Manuela Drăgoi; Mihnea-Alexandru Găman
Journal:  Medicina (Kaunas)       Date:  2021-11-23       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.